US2013203820A1PendingUtilityA1

Thiazolidinedione analogues

54
Assignee: METABOLIC SOLUTIONS DEV CO LLCPriority: Mar 16, 2006Filed: Jan 28, 2013Published: Aug 8, 2013
Est. expiryMar 16, 2026(expired)· nominal 20-yr term from priority
Inventors:Gerard R. ColcaRolf F. Kletzien
A61P 37/08A61P 37/06A61P 3/10A61P 43/00A61P 37/00A61P 9/00A61P 3/06A61P 25/00A61P 25/28A61P 3/04A61P 29/00A61P 25/16A61P 1/00A61P 1/04A61P 21/04A61P 19/02A61P 11/00A61K 31/4439A61K 31/4427A61K 31/4436
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to thiazolidinedione analogues that are useful for treating metabolic inflammation mediated diseases such as diabetes.

Claims

exact text as granted — not AI-modified
1 . A method of treating dyslipidemia comprising administering to a patient a pharmaceutical composition comprising Compound No. 1: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         20 - 26 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.